Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence (Q35160971)

6 August 2017

1 reference

title

Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence (English)

1 reference

6 August 2017

Guido Schnyder

1

1 reference

PubMed ID

12822737

6 August 2017

Gilles Rouvinez

series ordinal

2

1 reference

PubMed ID

12822737

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

35

1 reference

6 August 2017

3

1 reference

6 August 2017

156-163

1 reference

Homocysteine, B vitamins, and coronary artery disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine and cardiovascular disease: current evidence and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine and its disulfide derivatives: a suggested consensus terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Hyperhomocysteinaemia and adverse events complicating coronary catheter interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Plasma homocysteine levels and late outcome after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Plasma homocysteine levels and mortality in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocysteine and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310008206

10.1080/07853890310008206

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12822737